Back
Adaptive Biotechnologies Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
55
ADPT
Adaptive Biotechnologies
Last Price:
3.67
Seasonality Move:
16.34%
Sell
44
NBY
NovaBay Pharmaceuticals
Last Price:
0.20
Seasonality Move:
1.9%
Buy
55
Adaptive Biotechnologies (ADPT)
is a Buy
Is Adaptive Biotechnologies a Buy, Sell or Hold?
- The current Adaptive Biotechnologies [ADPT] share price is $3.72. The Score for ADPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- ADPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.12. The Score for NBY is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ADPT Stock Price Chart
What is Adaptive Biotechnologies's stock price today?
-
The Adaptive Biotechnologies share price today is $3.72
The current trend is moderately bullish and ADPT is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.12
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight buying pressure.
ADPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.24 | Buy |
| Relative Strength Index (14 RSI): | 63.6 | Buy |
| Chaikin Money Flow: | -1349660 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.51 - 3.47) | Buy |
| Bollinger Bands (100): | (2.91 - 4.31) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 68 | Buy |
| Chaikin Money Flow: | 19279670 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.08 - 0.1) | Buy |
| Bollinger Bands (100): | (0.09 - 0.17) | Sell |
ADPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.59 | Buy |
| 20-day SMA: | 3.07 | Buy |
| 50-day SMA: | 3.06 | Buy |
| 200-day SMA: | 4.42 | Sell |
| 8-day EMA: | 3.6 | Buy |
| 20-day EMA: | 3.27 | Buy |
| 50-day EMA: | 3.23 | Buy |
| 200-day EMA: | 4.51 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.09 | Buy |
| 20-day SMA: | 0.09 | Buy |
| 50-day SMA: | 0.1 | Buy |
| 200-day SMA: | 0.29 | Sell |
| 8-day EMA: | 0.1 | Buy |
| 20-day EMA: | 0.09 | Buy |
| 50-day EMA: | 0.11 | Buy |
| 200-day EMA: | 0.51 | Sell |
Adaptive Biotechnologies Earnings Growth & ADPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.03 per share, an increase this year of $0.11 per share, and an increase next year of $0.26 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.06 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Adaptive Biotechnologies Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||